APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intranasal Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Intranasal Vaccine Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchIntranasal Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Intranasal Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Intranasal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intranasal Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intranasal Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intranasal Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intranasal Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intranasal Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intranasal Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intranasal Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Intranasal Vaccine include Abbott, Beijing Wantai Biopharmaceutical Co., Ltd., Sanofi, GlaxoSmithKline, Changchun Baike Company, AstraZeneca, Serum Institute of India, PharmaJet and Crossject and INJEX Pharma GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intranasal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intranasal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Intranasal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intranasal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intranasal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intranasal Vaccine sales, projected growth trends, production technology, application and end-user industry.

Intranasal Vaccine Segment by Company

Abbott

Beijing Wantai Biopharmaceutical Co., Ltd.

Sanofi

GlaxoSmithKline

Changchun Baike Company

AstraZeneca

Serum Institute of India

PharmaJet and Crossject

INJEX Pharma GmbH

BioDiem

Bharat Biotech

Antares Pharma

Intranasal Vaccine Segment by Type

Flu Vaccine

COVID-19 Vaccines

Intranasal Vaccine Segment by Application

Hospital

Clinic

Intranasal Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intranasal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intranasal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intranasal Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intranasal Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Flu Vaccine Major Manufacturers Table 3. COVID-19 Vaccines Major Manufacturers Table 4. Global Intranasal Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Intranasal Vaccine Industry Trends Table 8. Intranasal Vaccine Industry Drivers Table 9. Intranasal Vaccine Industry Opportunities and Challenges Table 10. Intranasal Vaccine Industry Restraints Table 11. Global Intranasal Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Intranasal Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Intranasal Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Intranasal Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Intranasal Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Intranasal Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Intranasal Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Intranasal Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Intranasal Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Intranasal Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Intranasal Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Intranasal Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Intranasal Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Intranasal Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Intranasal Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Intranasal Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Intranasal Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Intranasal Vaccine Manufacturers, Product Type & Application Table 29. Global Intranasal Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Intranasal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Intranasal Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Intranasal Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Intranasal Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Intranasal Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Intranasal Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Intranasal Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Intranasal Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Intranasal Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Intranasal Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Intranasal Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Intranasal Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Intranasal Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Intranasal Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Intranasal Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Intranasal Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. Abbott Company Information Table 57. Abbott Business Overview Table 58. Abbott Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Abbott Intranasal Vaccine Product Portfolio Table 60. Abbott Recent Development Table 61. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information Table 62. Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview Table 63. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio Table 65. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Intranasal Vaccine Product Portfolio Table 70. Sanofi Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Intranasal Vaccine Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Changchun Baike Company Company Information Table 77. Changchun Baike Company Business Overview Table 78. Changchun Baike Company Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Changchun Baike Company Intranasal Vaccine Product Portfolio Table 80. Changchun Baike Company Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. AstraZeneca Intranasal Vaccine Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India Intranasal Vaccine Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. PharmaJet and Crossject Company Information Table 92. PharmaJet and Crossject Business Overview Table 93. PharmaJet and Crossject Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. PharmaJet and Crossject Intranasal Vaccine Product Portfolio Table 95. PharmaJet and Crossject Recent Development Table 96. INJEX Pharma GmbH Company Information Table 97. INJEX Pharma GmbH Business Overview Table 98. INJEX Pharma GmbH Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. INJEX Pharma GmbH Intranasal Vaccine Product Portfolio Table 100. INJEX Pharma GmbH Recent Development Table 101. BioDiem Company Information Table 102. BioDiem Business Overview Table 103. BioDiem Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. BioDiem Intranasal Vaccine Product Portfolio Table 105. BioDiem Recent Development Table 106. Bharat Biotech Company Information Table 107. Bharat Biotech Business Overview Table 108. Bharat Biotech Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bharat Biotech Intranasal Vaccine Product Portfolio Table 110. Bharat Biotech Recent Development Table 111. Antares Pharma Company Information Table 112. Antares Pharma Business Overview Table 113. Antares Pharma Intranasal Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Antares Pharma Intranasal Vaccine Product Portfolio Table 115. Antares Pharma Recent Development Table 116. North America Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 119. North America Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 120. North America Intranasal Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 121. North America Intranasal Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 122. North America Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 125. North America Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 126. North America Intranasal Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 127. North America Intranasal Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 128. North America Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Intranasal Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Intranasal Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. North America Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 133. North America Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 134. North America Intranasal Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 135. North America Intranasal Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 136. United States Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Canada Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Mexico Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 139. Europe Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 142. Europe Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 143. Europe Intranasal Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 144. Europe Intranasal Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 145. Europe Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 148. Europe Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 149. Europe Intranasal Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 150. Europe Intranasal Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 151. Europe Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Intranasal Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Intranasal Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 155. Europe Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 156. Europe Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 157. Europe Intranasal Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 158. Europe Intranasal Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 159. Germany Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 160. France Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 161. U.K. Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Italy Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 163. Russia Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Spain Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 166. Switzerland Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 167. Sweden Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 168. Poland Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 169. China Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 170. China Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 171. China Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 172. China Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 173. China Intranasal Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 174. China Intranasal Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 175. China Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 176. China Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 177. China Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 178. China Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 179. China Intranasal Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 180. China Intranasal Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 181. Asia Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 184. Asia Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 185. Asia Intranasal Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 186. Asia Intranasal Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 187. Asia Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 190. Asia Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 191. Asia Intranasal Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 192. Asia Intranasal Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 193. Asia Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Intranasal Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Intranasal Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. Asia Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 198. Asia Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 199. Asia Intranasal Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 200. Asia Intranasal Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 201. Japan Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 202. South Korea Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 203. India Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Australia Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Taiwan Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Intranasal Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Intranasal Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 210. SAMEA Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 211. SAMEA Intranasal Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 212. SAMEA Intranasal Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 213. SAMEA Intranasal Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Intranasal Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 216. SAMEA Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 217. SAMEA Intranasal Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 218. SAMEA Intranasal Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 219. SAMEA Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Intranasal Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Intranasal Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. SAMEA Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 224. SAMEA Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 225. SAMEA Intranasal Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 226. SAMEA Intranasal Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 227. Brazil Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Argentina Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Chile Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Colombia Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Peru Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Israel Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 234. UAE Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 235. Turkey Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Iran Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Egypt Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Intranasal Vaccine Distributors List Table 241. Intranasal Vaccine Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Intranasal Vaccine Image Figure 2. Global Intranasal Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intranasal Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Flu Vaccine Image Figure 5. COVID-19 Vaccines Image Figure 6. Global Intranasal Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Intranasal Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Intranasal Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Intranasal Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Intranasal Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Intranasal Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Intranasal Vaccine Sales (2021-2032) & (k units) Figure 16. Global Intranasal Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Intranasal Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Intranasal Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Intranasal Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Intranasal Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Intranasal Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Intranasal Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Intranasal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Intranasal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Intranasal Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Intranasal Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Intranasal Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Intranasal Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Intranasal Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Intranasal Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Intranasal Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Intranasal Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Intranasal Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Intranasal Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Intranasal Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Intranasal Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Intranasal Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Intranasal Vaccine Sales Share by Type (2021-2032) Figure 40. North America Intranasal Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Intranasal Vaccine Sales Share by Application (2021-2032) Figure 42. North America Intranasal Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Intranasal Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Intranasal Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Intranasal Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Intranasal Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Intranasal Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Intranasal Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Intranasal Vaccine Sales Share by Country (2021-2032) Figure 50. China Intranasal Vaccine Revenue Share by Type (2021-2032) Figure 51. China Intranasal Vaccine Sales Share by Type (2021-2032) Figure 52. China Intranasal Vaccine Revenue Share by Application (2021-2032) Figure 53. China Intranasal Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Intranasal Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Intranasal Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Intranasal Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Intranasal Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Intranasal Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Intranasal Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Intranasal Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Intranasal Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Intranasal Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Intranasal Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Intranasal Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Intranasal Vaccine Sales Share by Country (2021-2032) Figure 66. Intranasal Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Intranasal Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Flu Vaccine
  • COVID-19 Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott
  • Beijing Wantai Biopharmaceutical Co., Ltd.
  • Sanofi
  • GlaxoSmithKline
  • Changchun Baike Company
  • AstraZeneca
  • Serum Institute of India
  • PharmaJet and Crossject
  • INJEX Pharma GmbH
  • BioDiem
  • Bharat Biotech
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intranasal Vaccine Market by Type
  3. 1.2.1 Global Intranasal Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Flu Vaccine
  5. 1.2.3 COVID-19 Vaccines
  6. 1.3 Intranasal Vaccine Market by Application
  7. 1.3.1 Global Intranasal Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Intranasal Vaccine Market Dynamics
  1. 2.1 Intranasal Vaccine Industry Trends
  2. 2.2 Intranasal Vaccine Industry Drivers
  3. 2.3 Intranasal Vaccine Industry Opportunities and Challenges
  4. 2.4 Intranasal Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intranasal Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intranasal Vaccine Revenue by Region
  3. 3.2.1 Global Intranasal Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intranasal Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Intranasal Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Intranasal Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intranasal Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intranasal Vaccine Sales by Region
  9. 3.4.1 Global Intranasal Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intranasal Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Intranasal Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Intranasal Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intranasal Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Intranasal Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intranasal Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intranasal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intranasal Vaccine Sales by Manufacturers
  6. 4.2.1 Global Intranasal Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intranasal Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intranasal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intranasal Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intranasal Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intranasal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intranasal Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Intranasal Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intranasal Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Intranasal Vaccine Tier 1, Tier 2, and Tier 3
5 Intranasal Vaccine Market by Type
  1. 5.1 Global Intranasal Vaccine Revenue by Type
  2. 5.1.1 Global Intranasal Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intranasal Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intranasal Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intranasal Vaccine Sales by Type
  6. 5.2.1 Global Intranasal Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intranasal Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Intranasal Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intranasal Vaccine Price by Type
6 Intranasal Vaccine Market by Application
  1. 6.1 Global Intranasal Vaccine Revenue by Application
  2. 6.1.1 Global Intranasal Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intranasal Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intranasal Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intranasal Vaccine Sales by Application
  6. 6.2.1 Global Intranasal Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intranasal Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Intranasal Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intranasal Vaccine Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Intranasal Vaccine Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Beijing Wantai Biopharmaceutical Co., Ltd.
  8. 7.2.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
  12. 7.2.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Intranasal Vaccine Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Changchun Baike Company
  26. 7.5.1 Changchun Baike Company Company Information
  27. 7.5.2 Changchun Baike Company Business Overview
  28. 7.5.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changchun Baike Company Intranasal Vaccine Product Portfolio
  30. 7.5.5 Changchun Baike Company Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Intranasal Vaccine Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Serum Institute of India
  38. 7.7.1 Serum Institute of India Company Information
  39. 7.7.2 Serum Institute of India Business Overview
  40. 7.7.3 Serum Institute of India Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Serum Institute of India Intranasal Vaccine Product Portfolio
  42. 7.7.5 Serum Institute of India Recent Developments
  43. 7.8 PharmaJet and Crossject
  44. 7.8.1 PharmaJet and Crossject Company Information
  45. 7.8.2 PharmaJet and Crossject Business Overview
  46. 7.8.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
  48. 7.8.5 PharmaJet and Crossject Recent Developments
  49. 7.9 INJEX Pharma GmbH
  50. 7.9.1 INJEX Pharma GmbH Company Information
  51. 7.9.2 INJEX Pharma GmbH Business Overview
  52. 7.9.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
  54. 7.9.5 INJEX Pharma GmbH Recent Developments
  55. 7.10 BioDiem
  56. 7.10.1 BioDiem Company Information
  57. 7.10.2 BioDiem Business Overview
  58. 7.10.3 BioDiem Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 BioDiem Intranasal Vaccine Product Portfolio
  60. 7.10.5 BioDiem Recent Developments
  61. 7.11 Bharat Biotech
  62. 7.11.1 Bharat Biotech Company Information
  63. 7.11.2 Bharat Biotech Business Overview
  64. 7.11.3 Bharat Biotech Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bharat Biotech Intranasal Vaccine Product Portfolio
  66. 7.11.5 Bharat Biotech Recent Developments
  67. 7.12 Antares Pharma
  68. 7.12.1 Antares Pharma Company Information
  69. 7.12.2 Antares Pharma Business Overview
  70. 7.12.3 Antares Pharma Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Antares Pharma Intranasal Vaccine Product Portfolio
  72. 7.12.5 Antares Pharma Recent Developments
8 North America
  1. 8.1 North America Intranasal Vaccine Market Size by Type
  2. 8.1.1 North America Intranasal Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Intranasal Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Intranasal Vaccine Price by Type (2021-2032)
  5. 8.2 North America Intranasal Vaccine Market Size by Application
  6. 8.2.1 North America Intranasal Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Intranasal Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Intranasal Vaccine Price by Application (2021-2032)
  9. 8.3 North America Intranasal Vaccine Market Size by Country
  10. 8.3.1 North America Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intranasal Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Intranasal Vaccine Market Size by Type
  2. 9.1.1 Europe Intranasal Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intranasal Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Intranasal Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Intranasal Vaccine Market Size by Application
  6. 9.2.1 Europe Intranasal Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intranasal Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Intranasal Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Intranasal Vaccine Market Size by Country
  10. 9.3.1 Europe Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intranasal Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Intranasal Vaccine Market Size by Type
  2. 10.1.1 China Intranasal Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Intranasal Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Intranasal Vaccine Price by Type (2021-2032)
  5. 10.2 China Intranasal Vaccine Market Size by Application
  6. 10.2.1 China Intranasal Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Intranasal Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Intranasal Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intranasal Vaccine Market Size by Type
  2. 11.1.1 Asia Intranasal Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intranasal Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Intranasal Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Intranasal Vaccine Market Size by Application
  6. 11.2.1 Asia Intranasal Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intranasal Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Intranasal Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Intranasal Vaccine Market Size by Country
  10. 11.3.1 Asia Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intranasal Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intranasal Vaccine Market Size by Type
  2. 12.1.1 SAMEA Intranasal Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intranasal Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intranasal Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Intranasal Vaccine Market Size by Application
  6. 12.2.1 SAMEA Intranasal Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intranasal Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intranasal Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Intranasal Vaccine Market Size by Country
  10. 12.3.1 SAMEA Intranasal Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intranasal Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intranasal Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intranasal Vaccine Value Chain Analysis
  2. 13.1.1 Intranasal Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intranasal Vaccine Production Mode & Process
  6. 13.2 Intranasal Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intranasal Vaccine Distributors
  9. 13.2.3 Intranasal Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst